SCHEMBL5820645

SCHEMBL5820645

Nc1c(C(=O)Nc2ccc(Cl)cn2)cc(Cl)cc1C(=O)c1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 5/20 0.57
▸ KMT2A Q03164 5/20 0.57
▸ NPC1 O15118 6/20 0.55
▸ RAB9A P51151 6/20 0.55
▸ SMN1; SMN2 Q16637 4/20 0.55
▸ ALOX15 P16050 1/20 0.55
▸ HTT P42858 1/20 0.55
▸ TDP1 Q9NUW8 1/20 0.55
▸ F10 P00742 5/20 0.54
▸ TSHR P16473 2/20 0.53
▸ ALDH1A1 P00352 1/20 0.53
▸ PKM P14618 1/20 0.53
▸ CASP3 P42574 1/20 0.52
▸ SENP8 Q96LD8 1/20 0.52
▸ SENP7 Q9BQF6 1/20 0.52
▸ SENP6 Q9GZR1 1/20 0.52
▸ SORT1 Q99523 1/20 0.51
▸ RXFP1 Q9HBX9 1/20 0.51
▸ KDM4E B2RXH2 1/20 0.50
▸ TP53 P04637 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5805501 0.83 MEN1 (0.55) MEN1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL6592032 0.82 RAB9A (0.56) MEN1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL2989305 0.81 RAB9A (0.54) MEN1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL6261356 0.80 RAB9A (0.64) MEN1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL7069217 0.79 KMT2A (0.79) MEN1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL6595792 0.77 F10 (0.61) MEN1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL2001450 0.77 RAB9A (0.64) MEN1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL30338953 0.77 NPC1 (0.70) MEN1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL1998921 0.77 F10 (0.60) MEN1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL890674 0.77 NPC1 (0.70) MEN1KMT2ANPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1505966-A4 1,1-DISUBSTITUTED CYCLOALKYL DERIVATIVES AS FACTOR XA INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2006-08-30 — — EP disclosed
EP-1505966-A1 1,1-DISUBSTITUTED CYCLOALKYL DERIVATIVES AS FACTOR XA INHIBITORS Bristol-Myers Squibb Company (US) 2005-02-16 — — EP disclosed
WO-2003099276-A1 1,1-DISUBSTITUTED CYCLOALKYL DERIVATIVES AS FACTOR XA INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2003-12-04 — — WO disclosed
Send feedback